DIAGNOSTIC, NEUROSTIMULATING, AND THERAPEUTIC METHOD APPLIED TO BIOLOGICAL TARGETS THAT ARE NATURALLY INTEGRATED TO EACH OTHER
The present invention provides a method for coordinated neurostimulation of two or more biological targets are naturally integrated to each other such as nerves. The method includes disintegrating and separating the two or more biological targets from each other; and wrapping an electrode device around the separated biological targets. The electrode device may include suture holes, and the method, further includes a step of stitching the electrode device around the biological targets through the one or more suture holes. The electrode in the electrode device can electrically and stably contact the biological targets.
This application expressly claims the benefits and priority based on U.S. Provisional Application No. 62/890,580 filed Aug. 22, 2019, which is incorporated herein by references as if set forth in its entirety.
FIELD OF THE INVENTIONThe present invention generally relates to a diagnostic, neurostimulating, and/or therapeutic method applied to biological targets that are naturally integrated to each other. In general embodiments, provided are a method for coordinated stimulation of two or more integrated nerve components, and a lead, a device and a system designed for executing said method. Although the invention will be illustrated, explained and exemplified with a coordinated stimulation of anterior and posterior spinal nerve components for bladder control using a flap-shaped or ribbon-shaped lead, it should be appreciated that the present invention can also be applied to other integrated nerve components using other types of lead to treat other medical symptoms.
BACKGROUND OF THE INVENTIONNeurostimulation in medicine is a modulation of the nervous system's activity using invasive (e.g. microelectrodes) or non-invasive means (e.g. transcranial magnetic stimulation or transcranial electric stimulation, tES, such as tDCS or transcranial alternating current stimulation, tACS). Neurostimulation is particularly helpful for patients who are severely paralyzed or suffering from losses to functionality, such as movement of extremities or loss of internal organ functions. In the case of neural stimulation, mostly an electrical stimulation is utilized, and constant current waveform approaches are adopted.
For example, Giles Brindley introduced the first surgical implant to evacuate the bladder in paraplegic patients by directly stimulating intradurally the efferent nerves AND pertaining a rhizotomy (cutting) of the afferent nerves, that otherwise would inhibit the induced bladder contraction. Please see “Sacral anterior roots stimulation for bladder control” in Paraplegia 20:365-381, 1982. Other related references include J. Kutzenberger, B. Domurath, and D. Sauerwein, Spastic bladder and spinal cord injury: seventeen years of experience with sacral deafferentation and implantation of an anterior root stimulator, Artif Organs, 29(3) 239-41, March 2005; and Extradural implantation of sacral anterior root stimulator in spinal cord injury patients Castaño-Botero, Juan Carlos and Ospina-Galeano, Irma Amparo and Gómez-Illanes, Reynaldo and Lopera-Toro, Adrian Neurourol Urodyn 2016, 35/8, 970-974.
Advantageously, the present invention provides an improved diagnostic, neurostimulating, and therapeutic method applied to biological targets that are naturally integrated to each other. In an exemplary embodiment, the present invention introduces a special electrode that will achieve a similar or better result without cutting nerves.
SUMMARY OF THE INVENTIONOne aspect of the present invention provides diagnostic, neurostimulating, and/or therapeutic method, comprising (i) providing a medical device or system comprising a flexible and implantable electrode device, (ii) providing two or more biological targets in a patient, wherein the two or more biological targets are naturally integrated to each other, (iii) disintegrating and separating the two or more biological targets from each other; (iv) wrapping the electrode device around one or more of the separated biological targets, so that at least one electrode in the electrode device can electrically and stably contact the biological target(s); and (v) executing a diagnostic and/or therapeutic process on the biological target(s).
Another aspect of the invention provides a medical device or system as used in the diagnostic, neurostimulating, and/or therapeutic method described above.
The above features and advantages and other features and advantages of the present invention are readily apparent from the following detailed description of the best modes for carrying out the invention when taken in connection with the accompanying drawings.
The present invention is illustrated by way of example, and not by way of limitation, in the figures of the accompanying drawings and in which like reference numerals refer to similar elements. All the figures are schematic and generally only show parts which are necessary in order to elucidate the invention. For simplicity and clarity of illustration, elements shown in the figures and discussed below have not necessarily been drawn to scale. Well-known structures and devices are shown in simplified form, omitted, or merely suggested, in order to avoid unnecessarily obscuring the present invention.
In the following description, for the purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of the present invention. It is apparent, however, to one skilled in the art that the present invention may be practiced without these specific details or with an equivalent arrangement.
Where a numerical range is disclosed herein, unless otherwise specified, such range is continuous, inclusive of both the minimum and maximum values of the range as well as every value between such minimum and maximum values. Still further, where a range refers to integers, only the integers from the minimum value to and including the maximum value of such range are included. In addition, where multiple ranges are provided to describe a feature or characteristic, such ranges can be combined.
It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the invention. For example, when an element is referred to as being “on”, “connected to”, or “coupled to” another element, it can be directly on, connected or coupled to the other element or intervening elements may be present. In contrast, when an element is referred to as being “directly on”, “directly connected to”, or “directly coupled to” another element, there are no intervening elements present.
With reference to
In a preferred yet exemplary embodiment, the implantable electrode device comprises one, two or more suture holes, and the method further includes an optional step of (iv-b) stitching the implantable electrode device around the one or more biological targets through the one or more suture holes after step (iv) but before step (v).
In various embodiments of the invention, the two or more biological targets are naturally integrated to each other by connecting through a connective tissue. Alternatively, they may be naturally integrated to each other by encapsulating together inside a same confinement made of connective tissue. For example, an anterior segmental nerve (ASN) and a posterior segmental nerve (PSN) may be encapsulated together within an epineurium. As a result, step (iii) of disintegrating and separating the two or more biological targets from each other may be carried out by cutting the epineurium (e.g. a laminectomy).
As shown in
The flap 63 may have a front side 63F and a back side 63B. One of the electrodes 64a may have only one flat contacting surface 64aF that can electrically contact one of the biological targets. The contacting surface 64aF may be on the front side of the flap 63F, or on the back side of the flap 63B. Alternatively, one of the electrodes 64b may have only two flat contacting surfaces (64bF, 64bB) that can electrically contact one of the biological targets. One of the two contacting surfaces 64bF may be on the front side of the flap 63F, and another one 64bB is on the back side of the flap 63B, and vice versa.
In preferred embodiments, the flap 63 comprises one or more suture holes 66 (typically through holes) for stitching the flap 63 around the one, two or more biological targets.
In some embodiments where the flap comprises one or more suture holes for stitching the flap around the one or more nerves, the method may further include a step (iv-b) stitching the flap around the one or more nerves through the one or more suture holes.
In various exemplary embodiments of the invention, an implantable lead is used to stimulate anterior and posterior spinal nerve components.
In specific embodiments, the diagnostic and/or therapeutic method is a neurostimulating method for bladder control, and step (v) of executing a diagnostic and/or therapeutic process is executing a neurostimulation protocol for bladder control, providing a coordinated stimulation of anterior and posterior spinal nerve components for bladder control. The embodiments introduce a special electrode that will achieve a similar or better result without cutting nerves, as compared to the known technology. The blocking of the afferent nerves may be achieved by surgically separating the sacral spinal nerve into efferent (to the bladder) and afferent (to the spinal cord and brain) Using a stimulation protocol of the invention may be applied on the different nerve bundles. Efferent stimulation to create a bladder contraction and afferent nerve trunk to block the inhibition fibers.
Bladder evacuation in spinal cord injured patients may be accomplished via electrical nerve stimulation. Bladder and urethra are controlled from the brain traveling through the spinal cord to the sacrum and the final organs. Stimulating the entire sacral spinal nerve branch, containing the anterior ASN and posterior PSN nerve bundles results in a contraction of both, the bladder and the urethral outlet, effectively blocking the urine flow.
In a procedure, PSN are cut (irreversible rhizotomy) to suppress inhibitory nerve branches. ASN and PSN can be surgically separated after performing a laminectomy. This allows application of various independent stimulation and sensing (action potential) protocols on ASN and PSN for bladder evacuation and avoid a rhizotomy.
In various exemplary embodiments, stimulation protocols and waveforms specifically address the functions needed from the particular nerve branch. Examples of combinations include, but are not limited to the following: (1) stimulate ASN for bladder contractions+PSN to block nerve activity, (2) stimulate ASN+sense response on PSN: • generate optimized waveform for bladder contractions and Inhibition of PSN, (3) stimulate PSN+sense response on ASN: • generate optimized waveform for bladder contractions and inhibition of PSN; (4) applying alternating stimulation on PSN and ASN; (5) stimulated ASN and sense evoked potentials on ASN-1 to ASN-3 to detect latency differences, where large fibers have short and small sensory fibers have longer latencies: • analyze and develop stimulation protocols and waveforms to target specific nerve fiber to fire or to inhibited.
In
In the foregoing specification, embodiments of the present invention have been described with reference to numerous specific details that may vary from implementation to implementation. The specification and drawings are, accordingly, to be regarded in an illustrative rather than a restrictive sense. The sole and exclusive indicator of the scope of the invention, and what is intended by the applicant to be the scope of the invention, is the literal and equivalent scope of the set of claims that issue from this application, in the specific form in which such claims issue, including any subsequent correction.
Claims
1. A diagnostic and/or therapeutic method, comprising (i) providing a medical device or system comprising a flexible and implantable electrode device in the sacral area, (ii) providing two or more biological targets in a patient, wherein the two or more biological targets are naturally integrated to each other; (iii) disintegrating and separating the two or more biological targets from each other; (iv) wrapping the electrode device around one or more of the separated biological targets, so that at least one electrode in the electrode device can electrically and stably contact the biological target(s), and (v) executing a diagnostic and/or therapeutic process on the biological target(s) by stimulating the nerve branches in a coordinated way, preventing the posterior nerve branch to inhibit a bladder contraction.
2. The diagnostic and/or therapeutic method according to claim 1, wherein the two or more biological targets are naturally integrated to each other by connecting through a connective tissue.
3. The diagnostic and/or therapeutic method according to claim 1, wherein the two or more biological targets are naturally integrated to each other by encapsulating together inside a same confinement made of connective tissue.
4. The diagnostic and/or therapeutic method according to claim 3, wherein the two or more biological targets include an anterior segmental nerve (ASN) and a posterior segmental nerve (PSN) that are encapsulated together within an epineurium.
5. The diagnostic and/or therapeutic method according to claim 4, wherein the step (iii) of disintegrating and separating the two or more biological targets from each other is carried out by cutting the epineurium (e.g. a laminectomy).
6. The diagnostic and/or therapeutic method according to claim 5, which is a neurostimulating method for bladder control, wherein the step (v) of executing a diagnostic and/or therapeutic process is executing a neurostimulation protocol for bladder control.
7. The diagnostic and/or therapeutic method according to claim 1, wherein the implantable electrode device comprises a flexible non-conductive flap, one or more electrodes integrated with the flap, and one or more wires embedded within the flap and connected to the one or more electrodes, wherein the implantable electrode device is configured to wrap around one, two or more biological targets, so that one of the electrodes can electrically and stably contact one of the biological targets.
8. The diagnostic and/or therapeutic method according to claim 7, wherein the flap has a front side and a back side, wherein one of the electrodes has only one flat contacting surface that can electrically contact one of the biological targets, and wherein the contacting surface is on the front side of the flap, or on the back side of the flap.
9. The diagnostic and/or therapeutic method according to claim 7, wherein the flap has a front side and a back side, wherein one of the electrodes has only two flat contacting surfaces that can electrically contact one of the biological targets, and wherein one of the two contacting surfaces is on the front side of the flap, and another one is on the back side of the flap.
10. The diagnostic and/or therapeutic method according to claim 7, wherein the flap comprises one or more suture holes for stitching the flap around the one, two or more biological targets.
11. The diagnostic and/or therapeutic method according to claim 7, wherein the electrodes comprise microelectrodes, wherein the flap comprises one, two or more electrode blocks, and each block comprises an array of microelectrodes.
12. The diagnostic and/or therapeutic method according to claim 7, wherein the flap comprises two or more electrode blocks, and the blocks are arranged linearly along an elongation direction of the flap.
13. The diagnostic and/or therapeutic method according to claim 12, wherein the flap further comprises one, two or more suture holes located in the proximity of each block.
14. The diagnostic and/or therapeutic method according to claim 13, wherein two or more suture holes are arranged linearly along an elongation direction of the flap to form a hole-segment, and each electrode block is flanked by one or two hole-segments.
15. The diagnostic and/or therapeutic method according to claim 13, wherein the biological targets include one, two or more nerves, further comprising a step of (iv-b) stitching the flap around the one or more nerves through the one or more suture holes after step (iv) but before step (v).
16. The diagnostic and/or therapeutic method according to claim 7, wherein the flap further comprises one, two or more suture holes.
17. The diagnostic and/or therapeutic method according to claim 16, further comprising a step of (iv-b) stitching the flap around the one or more biological targets through the one or more suture holes after step (iv) but before step (v).
18. The medical device or system used in the diagnostic and/or therapeutic method of claim 1.
19. The medical device or system according to claim 18, which is a neurostimulator or a neurostimulating system.
Type: Application
Filed: Aug 24, 2020
Publication Date: Feb 25, 2021
Patent Grant number: 11420053
Inventor: Norbert Kaula (Arvada, CO)
Application Number: 17/001,577